"Designing Growth Strategies is in our DNA"

CAR T-cell Therapy Market Size, Share & Industry Analysis, By Product (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti, and Others), By Indication (Large B-cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, B-cell Acute Lymphoblastic Leukemia, Multiple Myeloma, and Others), By Age Group (Pediatric and Adults), By End User (Hospital-based CAR T-cell Treatment Centers, Standalone Cancer Treatment Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: September 14, 2026 | Format: PDF | Report ID: FBI108455

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 149
Download Free Sample

    man icon
    Mail icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann